Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to... see more

TSXV:BTI - Post Discussion

View:
Post by JDavenport on Nov 19, 2021 1:55pm

Stuff...

Much of the recent buying is being done by long term shareholders. I think that the efforts to accurately inform shareholders, to whatever degree accuracy has been achieved, have helped shareholders retain confidence in Bioasis. This will show itself as the story unfolds when the usual broad selling on news turns out to be limited because shareholders retain high expectations for Bioasis.

I think this confidence is warranted.

Keep an eye on Johnson & Johnson. That company's spin off of its commercial products division and the reduced baby-powder legal liabilities that the remaining J&J may face could result in some interesting initiatives on J&J's and subsidiary Janssen's parts. In addition to long rumoured activities between Bioasis and the J&J companies, there were some interesting comments made by J&J at the Sachs & Associates Alzheimer's Progress conference that Bioasis attended in May. J&J's comments seemed tailormade for Bioasis's strategic plan.

The Bioasis information circular and other AGM documents have been available for a day or two on SEDAR. 

I wouldn't expect to see news coming out between the dates that AGM voting starts and the AGM. News at any point from now on would mean that early shareholders may be voting without the same information that later voters would have. There may be a regulation about that but I have never read it if it exists.

Happy voting, everybody. I recommend full support for the whole thing. I have never seen Bioasis in such good shape as it is right now. The market hasn't quite grasped that yet but it will if DrDR delivers as seems both apparent and imminent.

jd
Comment by beenthere on Nov 19, 2021 5:39pm
Show Us The Money!! Too Simple!
Comment by JDavenport on Nov 19, 2021 6:39pm
It's anything but simple, beenthere, which is why you and the rest of the market haven't "gotten it" yet.  Almost 30 drugs and disorders scattered around the pipeline and I've written about almost all of it. Nah, it's certainly not simple, except to people who get bogged down and can't really absorb the material and its meaning. Things are always simple for ...more  
Comment by chrispi on Nov 19, 2021 7:39pm
well said JD, well said!
Comment by beenthere on Nov 20, 2021 7:33pm
Should have known better! A copy writer that does not comprend what he reads! Lets try this again. Show us the money (deals)! Too simple!
Comment by fatboy92 on Nov 24, 2021 2:02am
JD, curious about the persistent hammering of the bid? I'm pretty sure that you had previously made a comment that you thought you knew who was behind this and or market manipulation and that you might reveal it too the shareholders that are interested in what playing out. I know beenthere only wants you to show him the money and the profit only wants to create a following of like minded ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities